Microdiscectomy and non-surgical disc treatments each address different aspects of disc-related pain, and the right path depends on the individual patient's diagnosis, imaging findings, and treatment history. This guide reviews how each approach works, what risks and limitations to consider, and how candidacy for biologic disc repair is evaluated.

Learn which patients are most likely to benefit from intra-annular fibrin injection for annular tears, and how our clinical team evaluates candidacy for biologic disc repair.

Veterans with degenerative disc disease often face a fusion recommendation — but non-surgical options like intra-annular fibrin injection may preserve mobility and address annular tears without permanent restrictions. Candidacy and outcomes vary by individual.

Discogenic pain — driven by annular tears and degenerative disc disease — is a leading but frequently misdiagnosed source of chronic back and neck pain. Learn what it is, how it is diagnosed, why conventional treatments often fall short, and how biologic disc repair may offer a non-surgical path forward.

A phased recovery guide for patients after intra-annular fibrin injection or biologic disc repair. Learn what to expect at each stage and how to safely return to the activities you value — at a pace your healing disc can support.

Veterans with chronic back pain exploring alternatives to spinal fusion may benefit from intra-annular fibrin injection — a biologic treatment targeting annular tears without the permanence or recovery burden of surgery. Candidacy is evaluated individually; outcomes vary by patient.